CN104447801A — 用于制备咪唑并[2,1-b][1,3]苯并噻唑衍生物的方法
Assigned to Ambit Bioscience Corp · Expires 2015-03-25 · 11y expired
What this patent protects
本文提供的是用于制备N-(5-叔丁基-异噁唑-3-基)-N′-{4-[7-(2-吗啉-4-基-乙氧基)咪唑并[2,1-b][1,3]苯并噻唑-2-基]苯基}脲或其药学上可接受的盐、溶剂化物、水合物或多晶型物的方法。N-(5-叔丁基-异噁唑-3-基)-N′-{4-[7-(2-吗啉-4-基-乙氧基)咪唑并[2,1-b][1,3]苯并噻唑-2-基]苯基}脲用于治疗、预防和/或控制疾病或病症，包括但不限于增生性疾病、FLT-3介导的疾病和癌症。N-(5-叔丁基-异噁唑-3-基)-N′-{4-[7-(2-吗啉-4-基-乙氧基)咪唑并[2,1-b][1,3]苯并噻唑…
USPTO Abstract
本文提供的是用于制备N-(5-叔丁基-异噁唑-3-基)-N′-{4-[7-(2-吗啉-4-基-乙氧基)咪唑并[2,1-b][1,3]苯并噻唑-2-基]苯基}脲或其药学上可接受的盐、溶剂化物、水合物或多晶型物的方法。N-(5-叔丁基-异噁唑-3-基)-N′-{4-[7-(2-吗啉-4-基-乙氧基)咪唑并[2,1-b][1,3]苯并噻唑-2-基]苯基}脲用于治疗、预防和/或控制疾病或病症，包括但不限于增生性疾病、FLT-3介导的疾病和癌症。N-(5-叔丁基-异噁唑-3-基)-N′-{4-[7-(2-吗啉-4-基-乙氧基)咪唑并[2,1-b][1,3]苯并噻唑-2-基]苯基}脲由以下结构代表：
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.